Metabolic syndrome: Early identification prevents type II diabetes and cardiovascular disease

Indian Journal of Clinical Biochemistry

Volumn 22, Issue 1, 2007, Pages 1-3

  Sharma, Praveen ^a   Mishra, Sandhya ^a  

^a SMS MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; EARLY DIAGNOSIS; EDITORIAL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LABORATORY DIAGNOSIS; LIFESTYLE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; STROKE; WORLD HEALTH ORGANIZATION;

EID: 33947123614     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02912872     Document Type: Editorial

References (16)

1. Reaven GM. Role of Insulin Resistance in Human Disease. Diabetes 1988; 37: 1595-1607.
2. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO Department of Noncommunicable Disease Surveillance, 1999.
3. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J. Am. Med. Assoc. 2001; 285: 2486-97.
4. International Diabetes Federation. New IDF worldwide definition of the metabolic syndrome. Press conference, Ist International congress on Pre-diabetes" and the metabolic syndrome. Berlin, Germany. April 14, 2005 (www.idf.org).
5. Enas A Enas @ http://www.cadiresearch.com/publications.htm
6. Mckeigue PM, Shah B, Marmott MG. Relationship of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-6.
7. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leption and insulin resistance in Asian Indian men. J. Clin Endocrinol Metab 1999; 84: 137-44.
8. Enas EA, Yusuf S, Mehta JL. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol 1992; 70: 945-9.
9. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84: 2329-35.
10. World Health Organization. WHO recommendations: Obesity: Preventing and Managing the Global Epidemic. Geneva, World Health Org. 2000.
11. Wilson PWF, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999; 159: 1104-9.
12. Golden SH, Folsom Ar, Coresh J, Sharrett AR, Szklo M, Brancati F. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. Diabetes 2002; 51: 3069-76.
13. Girman CJ, Rhodes T, Clearfield M, Beere PA, Mercuri M. Metabolic syndrome and risk of cardiovascular outcome in the placebo groups of two large clinical trials. http://aha.agora.com/abstractiviewer/results.asp
14. Domanski M, Proschan M, Maryland B. The Metabolic Syndrome. JACC 2004; 43(8): 1396-8.
15. Sharma P, Mishra S, Ajmera P and Mathur S. Oxidative Stress in metabolic syndrome. Indian J Clin Biochem 2005; 20 (1): 150-4.
16. Kcriakas D, Willerson J. Metabolic syndrome epidemic. Circulation 2006; 108: 1552-3.